68-3

96/130

) Hirakata T, Matsuda A, Yokomizo T: Leukot-riene B4 receptors as therapeutic targets for ophthalmic diseases. Biochim Biophys Acta Mol Cell Biol Lipids, 2020; 1865: 158756.) Ishimine M, Yokomizo T, Lee-Okada H.C: Carboxylesterase 2: A Key Enzyme in Drug and Prodrug Metabolism. Juntendo Med J, 2020; 66: 120-124.) Okuno T, Yokomizo T: Metabolism and biological functions of 12(S)-hydroxyhepta-deca-5Z,8E,10E-trienoic acid. Prostaglandins and Other Lipid Mediators, 2020; 152: 106502.) Yasukawa K, Okuno T, Yokomizo T: Eicosa-noids in Skin Wound Healing. Int J Mol Sci, 2020; 21.) Ishii Y, Okuno T, Yokomizo T: Identification and pathophysiological roles of LTB4 recep-tors BLT1 and BLT2. Lipid signaling and metabolism. Academic Press Inc, 2020: 223-245.2922020; 35: 1437-1448.) Jimbo K, Okuno T, Ohgaki R, Nishikubo K, Kitamura Y, Sakurai Y, Quan L, Shoji H, Kanai Y, Shimizu T, Yokomizo T: A novel mutation in the SLCO2A1 gene, encoding a prostaglandin transporter, induces chronic enteropathy. PLoS ONE, 2020; 15: e0241869.) Kaji S, Irino T, Kusuhara M, Makuuchi R, Yamakawa Y, Tokunaga M, Tanizawa Y, Bando E, Kawamura T, Kami K, Ohashi Y, Zhang S, Orita H, Lee-Okada H.C, Fukunaga T, Terashima M: Metabolomic profiling of gastric cancer tissues identified potential biomarkers for predicting peritoneal recur-rence. Gastric Cancer, 2020; 23: 874-883.) Koga T, Sasaki F, Saeki K, Tsuchiya S, Okuno T, Ohba M, Ichiki T, Iwamoto S, Uzawa H, Kitajima K, Meno C, Nakamura E, Tada N, Fukui Y, Kikuta J, Ishii M, Sugimoto Y, Nakao M, Yokomizo T: Expression of leukotriene B4 receptor 1 defines functionally distinct DCs that control allergic skin inflammation. Cell Mol Immunol, 2020. In press 7 8 9 10) Matsumoto Y, Matsuya Y, Nagai K, Amagase K, Saeki K, Matsumoto K, Yokomizo T, Kato S: Leukotriene B4 Receptor Type 2 Acceler-ates the Healing of Intestinal Lesions by Promoting Epithelial Cell Proliferation. Journal of Pharmacology and Experimental Thera-peutics, 2020; 373: 1-9. 11) Nakajima S, Ogawa N, Yokoue N, Tachibana H, Tamada K, Okazawa M, Sato A, Oyama T, Abe H, Kamiya T, Yoshimori A, Yoshizawa K, Inoue S, Yokomizo T, Uchiumi F, Abe T, Tanuma S.I: Trimebutine attenuates high mobility group box 1-receptor for advanced glycation end-products inflammatory signaling pathways. Biochemical and Biophysical Research Communications, 2020; 533: 1155-1161. 12) Nakao S, Yamada S, Tsuda K, Yokomizo T, Sato T, Tanoue S, Hiraki T: Intrathecal administration of nusinersen for spinal muscular atrophy: report of three cases with severe spinal deformity. JA Clin Rep, 2020; 6: 28. 13) Suzumura A, Kaneko H, Funahashi Y, Takayama K, Nagaya M, Ito S, Okuno T, Hirakata T, Nonobe N, Kataoka K, Shimizu H, Namba R, Yamada K, Ye F, Ozawa Y, Yokomizo T, Terasaki H: n-3 Fatty Acid and Its Metabolite 18-HEPE Ameliorate Retinal Neuronal Cell Dysfunction by Enhancing Muller BDNF in Diabetic Retinopathy. Diabetes 2020; 69: 724-735.＊ 14) Takahashi S.S, Sou Y.S, Saito T, Kuma A, Yabe T, Sugiura Y, Lee H.C, Suematsu M, Yokomizo T, Koike M, Terai S, Mizushima N, Waguri S, Komatsu M: Loss of autophagy impairs physiological steatosis by accumula-tion of NCoR1. Life Sci Alliance, 2020; 3: e201900513.＊ 15) Uzawa H, Kohno D, Koga T, Sasaki T, Fukunaka A, Okuno T, Jo-Watanabe A, Kazuno S, Miyatsuka T, Kitamura T, Fujitani Y, Watada H, Saeki K, Yokomizo T: Leukot-riene A4 hydrolase deficiency protects mice from diet-induced obesity by increasing energy expenditure through neuroendocrine axis. FASEB Journal, 2020; 34: 13949-13958. 16) Yuki K, Bu W, Eckenhoff R.G, Yokomizo T, Okuno T: The role of propofol hydroxyl group in 5-lipoxygenase recognition. Biochemical and Biophysical Research Communications, 2020; 525: 909-914.〈Reviews〉 1 2 3 4〈Books〉 1